Project Details
Description
Dr. Petrukhin' s overall goal of this project is to develop a small molecule therapy that reduces the accumulation of toxic lipofuscin byproducts to benefit patients with Stargardt disease
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/19 → 6/30/20 |
Funding
- Foundation Fighting Blindness: US$299,132.00
ASJC Scopus Subject Areas
- Pharmacology
- Biochemistry, Genetics and Molecular Biology(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.